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D
uring the last two decades, many
studies have focused on the pivotal
role of the hypothalamus in the
control of energy metabolism (1). Hypo-
thalamic nuclei, particularly the arcuate
and the ventromedial, receive numerous
peripheral inputs from adipokines (lep-
tin, adiponectin, and resistin) and free
fatty acids. These signals of “nutrient
abundance” lead to the activation of mul-
tiple hypothalamic pathways that overlap
and generate a plethora of central and pe-
ripheralresponses(2).Inthiscontext,the
central neuronal signals generated by in-
sulinhavebeenthemostextensivelystud-
ied (3).
The pivotal experiment performed by
Woods et al. (4) in the late 1970s showed
that intracerebral infusion of insulin in
baboons reduced food intake and body
weight and paved the way for intense sci-
entiﬁc investigation over subsequent
years by highlighting the key role of insu-
lin at the central nervous system (CNS)
level. Insulin receptors (5) and compo-
nents of the insulin signaling pathway (6)
are widely distributed in the brain. Insu-
lin interacts with its binding sites by
crossing the blood-brain barrier through
a receptor-mediated and saturable trans-
port mechanism (7), although it has been
hypothesized that insulin is also synthe-
sized in the brain (7).
Considerable evidence has been gen-
erated to indicate that insulin can modu-
late the expression of neuropeptides
involved in the regulation of food intake
withintheCNS(8)andalsocaninﬂuence
glucoregulationviaCNSconnectionsthat
regulate hepatic glucose production (9),
glycogen synthesis in the skeletal muscle
(10), and fat metabolism in adipocytes
(11). By activating its receptors, insulin
directly suppresses prepro-NPY mRNA
transcriptioninthearcuatenucleus,lead-
ing to a reduction in NPY and a decrease
infoodintake(12),whereasintracerebro-
ventricular delivery of insulin increases
the expression of pro-opiomelanocortin
(POMC) (13) (Fig. 1). This hypothalamic
modeofinsulinactionresemblesthewell-
known effect of leptin, suggesting that
these two hormones act in concert in the
hypothalamus (14). Leptin is an adipo-
kine that primarily is produced by adipo-
cytes. Leptin production and plasma
levels are correlated with adipocyte size
and triglyceride content, which increase
in obesity and overfeeding and decrease
with weight loss. Similar to insulin, leptin
crosses the blood-brain barrier through a
saturable transport mechanism (15). The
activation of neuronal leptin receptors in-
volves the Janus kinase/signal trans-
ducer and activator of transcription
(Jak-STAT) pathway that culminates in
the translocation of STAT3 into the nu-
cleus and the transcription of neu-
ropeptides (15). The main effects of
leptin in the CNS are the inhibition of
NPY and AgRP neurons and the activation
of POMC neurons in the arcuate nucleus.
Thus, leptin reduces food intake, stimu-
lates thermogenesis, and enhances lipid
oxidation and insulin sensitivity in pe-
ripheral organs (15). Like insulin, leptin
isasignalof“nutrientabundance,”evenif
itsabilitytosignalexcessenergystorageis
weak. Obese individuals have high
plasma leptin levels but an impaired re-
sponse to the increased levels of this adi-
pokine,suggestingthepresenceof“leptin
resistance.”Thispathologicalconditionis
associated with impaired leptin transport
across the blood-brain barrier, causing re-
duced hypothalamic leptin signaling. This
results in an increase in food intake and tri-
glyceride storage, mainly in adipose tissue
andliver,andgeneratesaviciouscyclelead-
ing to excessive fat weight gain.
Both leptin and insulin signaling are
knowntodirectlytargetPOMCandAgRP
neurons, through a complex interaction
that only recently has started to be eluci-
dated (16). By activation/inhibition of a
seriesofintracellularconvergingcascades
in the CNS, leptin and insulin cross-talk
via the phosphatidylinositol (PI) 3-kinase
pathway (16). Blockade of PI 3-kinase ac-
tivation by LY294002 promotes the inhi-
bition of both insulin and leptin-induced
anorexia in animals (17). Therefore, the
PI 3-kinase pathway may be considered
the main mediator of leptin and insulin
effects on food intake. However, the acti-
vationofPI3-kinasebyinsulinandleptin
may differ at the level of individual cells
(18). The two hormones act in concert on
POMC neurons, whereas they display
contrasting effects in AgRP neurons (18).
The transcriptional control of neu-
ropeptide expression is not the only way
by which insulin and leptin may regulate
the neuronal circuits controlling food in-
take.TheactivationofPI3-kinasemay,in
fact, regulate electrical activity via stimu-
lation of ATP-sensitive potassium (KATP)
channels in the neuronal target cells (19).
This activation leads to an outward ﬂow
of K
 ions, inducing hyperpolarization
and a reduced activity of the target neu-
ron. However, at this level, insulin and
leptin may regulate electrical activity in
different ways, as documented in some
POMC neurons (19,20). This divergent
ability of the two hormones to modulate
electric activity of hypothalamic neurons
is well depicted by the comparison of the
two phenotypes obtained by the brain-
speciﬁc knockout of insulin and leptin
receptors, respectively. Only insulin re-
ceptor neuronal deletion is associated
with a constitutive severe state of obesity
(21). Mice lacking the insulin receptor in
the brain developed obesity only after a
high-fat diet was administered (22).
The neuronal integrity of the insulin
receptor signaling also is required for the
maintenance of normal glucose ho-
meostasis. In fact, mice with a neuron-
speciﬁc insulin receptor knockout
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lin resistance (21). Consistent with this,
antisense oligodeoxynucleotide directed
against the insulin receptor caused not
only hyperphagia and increased fat mass,
but also a state of insulin resistance (23).
Changesinglucosehomeostasismaysim-
ply reﬂect, and be secondary to, the con-
comitant changes in energy balance.
Therefore, to investigate the central ef-
fects of insulin, independent of its pleio-
tropic peripheral actions, Obici et al. (9)
administered intracerebroventricular
agonists and antagonists of insulin signal-
ing in the presence of basal circulating
insulin levels to detect whether hepatic
insulin action was affected. They found
that infusion of either insulin or small-
molecule insulin mimetic agents into the
third cerebral ventricle suppressed glu-
cose production. Conversely, central an-
tagonism of insulin signaling impaired
the ability of circulating insulin to inhibit
glucose production. This neuronal action
ofinsulinonglucoseproductionhasbeen
shown to be mediated by central KATP
channels, because the sulfonylurea tolbu-
tamide abolished this effect (9).
Additional studies have substantiated
the hypothesis that insulin controls glu-
cose metabolism at the CNS level. Thus,
KATP channels in hypothalamic neurons
are activated by insulin and inﬂuence he-
patic glucose production by decreasing
glucose-6-phosphatase and phosphoenol-
pyruvate-carboxikinase, effects that are
mediated by the autonomous nervous
system (24) (Fig. 1).
Ithasbeenshownthatneuronalinsu-
lin receptor activation directly regulates
hepatic interleukin-6 (25) by a mecha-
nism involving AgRP-expressing neurons
in the hypothalamus. Insulin acts cen-
trally on AgRP neurons, causing activa-
tion of PI 3-kinase. The consequent
activation of KATP channels results in the
reduced release of AgRP. Silencing of
these cells modulates hepatic metabo-
lism, leading to increased interleukin-6
expression and decreased glucose-6-
phosphatase expression (26). To further
investigate the contribution of brain-
insulinsignalingversusperipheralinsulin
signaling on the development of insulin
resistance, Koch et al. (11) generated two
acutely inducible insulin receptor–
deﬁcient mouse models: one with a re-
duction of insulin receptor number in all
tissues of the body, including the CNS,
and another lacking the insulin receptor
only in the peripheral nervous system.
These models of inducible insulin resis-
tance are of considerable interest, be-
cause the results are devoid of any
developmental compensation and,
thus, bypass any changes that arise from
deletion of the insulin receptor during
embryonic development. By comparing
the phenotypes of the two groups of ani-
mals, it was found that central neuronal
insulin also has an important role in the
controloflipogenesisinperipheraladipo-
cytes (11) and increases fat mass, fat cell
size, and adipose tissue lipoprotein lipase
expression. Therefore, this study demon-
strated differential, partially counterbal-
ancing actions of insulin in the CNS: a
well-knowncatabolicfunctionviacontrol
of food intake, but also an anabolic func-
tion via stimulation of lipogenesis. A sa-
lient point was that the mice lacking CNS
insulin signaling suffered from more se-
verehyperglycemiathanthemiceinwhom
insulin signaling was impaired only at the
peripheral level, conﬁrming the pivotal role
of the neuronal insulin receptor in the con-
trol of peripheral glucose metabolism (11).
Accordingtotheseﬁndings,impaired
glucosemetabolismandobesitymayarise
from disruptions of hypothalamic insulin
signaling (Fig. 2). It is still not clear how
the genetic background and the environ-
mentmayaffecttheseneuronalpathways.
High-energy or fat-enriched diets may
work, not only through an impaired abil-
ity of insulin to activate the peripheral PI
3-kinase pathway, but also by negatively
modifying the intracellular insulin signal-
ing in the hypothalamus (27). Recent
studies have demonstrated that cerebral
insulin resistance also may occur in hu-
mans. By means of a magneto-encephalo-
Figure 1—The upper part of the ﬁgure shows the mechanism by which insulin acting at the brain level, and precisely at the hypothalamus, may
modulate glycemia by reducing food intake. The lower part shows how insulin receptor signaling is required for the maintenance of normal glucose
homeostasis. KATP channels in hypothalamic neurons are activated by insulin and inﬂuence hepatic glucose production, an effect that is mediated by
the autonomous nervous system.
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hyperinsulinemic-euglycemic clamp, an
impairedcorticalneuronalresponsetoin-
sulin was demonstrated in obese subjects
and in individuals with the Gly972Arg
polymorphism in IRS-1, a genetic condi-
tion associated with type 2 diabetes.
However, the reduced neuronal response
to insulin in the two pathological condi-
tions (obesity versus genetic predisposi-
tion to develop type 2 diabetes) showed a
different magneto-encephalographic pat-
tern, suggesting that 1) different mecha-
nisms can lead to cerebral insulin
resistanceand2)centralinsulinresistance
may not only be a consequence of, but
also a starting point for, the development
of obesity and type 2 diabetes (28).
In summary, the brain is an insulin-
sensitive tissue and, in association with
other nutrient and adiposity signals, such
as fatty acids (29), amino acids (30), and
leptin, may play an important role in the
regulation of energy balance and glucose
homeostasis.Hence,animpairmentofthe
fuel-sensing mechanisms in the CNS may
lead to both weight gain and dysregula-
tion of plasma glucose levels. Diet, rather
thanobesityperse,seemstoplayagreater
role in inducing a state of central insulin
resistance (31). However, the ensuing
obesity may further reduce the neuronal
sensitivity to peripheral signals, such as
insulinandleptin.Thesepathologicalpro-
cesses, in turn, exacerbate obesity and the
hyperinsulinemic state, leading to overt hy-
perglycemia,andthusgenerateaviciouscy-
cle that, in combination with -cell
dysfunction,progressestodiabetes.Thefu-
turewilldivulgewhetherrestorationofcen-
tral neuronal signaling will be beneﬁcial for
both obesity and diabetes.
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